Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,671 | -1,469 | -541 | -1,859 | -1,196 |
| Depreciation Amortization | 259 | 243 | 167 | 185 | 37 |
| Other Working Capital | 363 | 198 | 62 | 121 | 73 |
| Other Operating Activity | 841 | 832 | 156 | 1,122 | 841 |
| Operating Cash Flow | $-208 | $-196 | $-157 | $-431 | $-245 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $0 | $0 | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 264 | 264 | 264 | 794 | 222 |
| Debt Issued | 8 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 0 | 0 | 0 | 20 | 20 |
| Other Financing Activity | -233 | -233 | -233 | -250 | 0 |
| Financing Cash Flow | $39 | $31 | $31 | $564 | $242 |
| Beginning Cash Position | 170 | 170 | 170 | 36 | 36 |
| End Cash Position | 1 | 4 | 44 | 170 | 33 |
| Net Cash Flow | $-169 | $-165 | $-126 | $133 | $-3 |
| Free Cash Flow | |||||
| Operating Cash Flow | -208 | -196 | -157 | -431 | -245 |
| Free Cash Flow | -208 | -196 | -157 | -431 | -245 |